Learn about three key technology areas representing Artificial Intelligence in diagnostics and drug development in this LexisNexis® Classification report.
The Artificial Intelligence (AI) wave is sweeping the world and taking over one industry at a time. It is everywhere around us – from suggesting what to view or buy, categorizing our photos/emails, even figuring out the fastest route to reach our destination.
With the many applications of AI, you can see an increase of applications within the healthcare sector. This can range from accessing medical care virtually to the production of new drug treatments which can then be made more readily available for us.
This report looks at the organizations and technologies dominating this patent landscape and have spotted some interesting trends. We have looked at three key technology areas representing AI in Diagnostics and Drug Development:
But who owns these technologies and is dominating this innovative space?
Our report shows the latest trends emerging in this patent landscape and how the major tech companies are dominating this space.
Become more effective at managing your patent portfolio, identify worldwide relevant patents and technology trends, assess the competitive landscape, and find partners and licensing opportunities.
Improve innovation with a clearly defined IP strategy that is connected to the business goals and alerts for new entrants and potential partners.
Base decision making on true patent portfolio strength and quality indicators while relying on industry-proven KPIs to track your competitors’ progress.
Answer key questions to define international patent filing strategy, increase portfolio efficiency, and identify competitive strengths and weaknesses.
Identify disruptive innovations and promising startups to help you gain a competitive edge.
Stay one step ahead of your competition, disruptive technologies, important patent activity in China, and/or NPE threats. Efficiently assess the value or risk of acquisition targets.
With analytics on all patent portfolios in all technologies, you can evaluate your most valuable patents for licensing and even identify potential licensees.
